SciSparc Ltd.
NASDAQ
Closed
Jul 29, 2026
Day's Range
5.6052 wk Range
2.98Key Statistics
Symbol
SPRC
Name
SciSparc Ltd.
Currency
USD
Exchange
NASDAQ
High
10.13
Low
5.6
Open
‪6.24‬
Last
‪8.54‬
Market Cap
3.05M
Pe Ratio
‪0.05‬
Volume
492.26K
Average Volume
78.80K
Dividend Yield
‪0.00%‬
Change
3.21
Percent Change
60.23
Timestamp
2026-07-29
Close
8.54
Today Range Start
‪5.60‬
Today Range End
‪10.13‬
52 Week Range Start
‪2.98‬
52 Week Range End
‪80.10‬
Type
Stocks
Country
Israel
Historical Data - SPRC - SciSparc Ltd.
Historical Data
Market Cap - SPRC - SciSparc Ltd.
Market Cap
2026-07-28
3.05M
2026-07-27
2.87M
2026-07-24
3.05M
2026-07-23
3.27M
2026-07-22
2.77M
2026-07-21
2.72M
2026-07-20
2.69M
2026-07-17
2.86M
2026-07-16
3.07M
2026-07-15
2.80M
Splits - SPRC - SciSparc Ltd.
Splits
2026-03-04
1-for-9 split (9)
Earnings - SPRC - SciSparc Ltd.
Earnings
Balance Sheet - SPRC - SciSparc Ltd.
Balance Sheet
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
 Assets | 7.62M | 10.34M | 11.18M | 10.60M | 9.91M | 2.56M |
| Liabilities | 2.47M | 1.40M | 1.59M | 4.15M | 1.77M | 1.13M |
| Shareholders Equity | 5.14M | 8.93M | 9.58M | 6.44M | 8.14M | 1.43M |
Cash Flow - SPRC - SciSparc Ltd.
Cash Flow
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Operating Activities | - | - | - | - | - | - |
| Investing Activities | - | - | - | - | - | - |
| Financing Activities | - | - | - | - | - | - |
| End Cash Position | 4.59M | 1.54M | 2.07M | 3.57M | 6.87M | 1.94M |
| Income Tax Paid | - | - | - | - | - | - |
| Interest Paid | - | - | - | - | - | - |
| Free Cash Flow | -4.13M | -5.10M | -5.88M | -12.78M | -5.09M | -4.30M |
Income Statement - SPRC - SciSparc Ltd.
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 856K | 1.30M | 2.87M | 1.34M | 0 | 0 |
| Cost of Goods | 225K | 800K | 683K | 322K | 0 | 0 |
| Gross Profit | 631K | 506K | 2.19M | 1.02M | 0 | 0 |
| Operating Expense | - | - | - | - | - | - |
| Operating Income | -8.74M | -7.24M | -5.77M | -8.28M | -5.76M | -2.55M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -5.59M | -635K | -79K | 6.94M | -3K | -124K |
| Pre Tax Income | -12.56M | -7.48M | -5.86M | -2.57M | -5.78M | -3.53M |
| Income Tax | 0 | -14K | 22K | 14K | 0 | 0 |
| Net Income | -12.56M | -7.47M | -5.88M | -2.59M | -5.78M | -3.53M |
| EPS Basic | - | 203.889996 | 2.37K | -309.381714 | -1.91K | -2.6 |
| EPS Diluted | - | 203.889996 | 2.37K | -309.381714 | -1.91K | -2.86 |
| Basic Shares Outstanding | - | 30.82K | 2.15K | 8.37K | 3.03K | 9.92K |
| Diluted Shares Outstanding | - | 30.82K | 2.15K | 8.37K | 3.03K | 9.92K |
| Ebit | -12.55M | -7.45M | -5.85M | -2.54M | -5.77M | -3.51M |
| Ebitda | -7.20M | -6.76M | -5.44M | -9.41M | -5.74M | -3.22M |
| Net Income Continuous Operations | -12.56M | -7.47M | -5.88M | -2.59M | -5.78M | -3.53M |
| Minority Interests | 385K | 1.18M | 761K | 0 | 0 | 53K |
| Preferred Stock Dividends | - | - | - | - | - | - |
Profile - SPRC - SciSparc Ltd.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Biotechnology
Employees
3
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company focused on developing cannabinoid-based therapies for central nervous system disorders. Its primary drug development programs include SCI-110, targeting Tourette syndrome, Alzheimer’s disease and agitation, and obstructive sleep apnea, and SCI-110 for autism spectrum disorder and status epilepticus, conducted through its majority-owned subsidiary NeuroThera Labs Inc. The company also advances intellectual property in areas such as opioid-N-acylethanolamine combinations for pain management, neuroplastogen therapies, and the MUSE system, an endoscopic device for gastroesophageal reflux disease treatment. Additionally, SciSparc sells hemp seed oil-based nutraceutical products, including gummies, oil capsules, creams, and beauty treatments, via online marketplaces. It pursues innovative initiatives like quantum computing-enabled 3D protein modeling to enhance AI-driven drug discovery for neurological conditions. Founded in 2004 and headquartered in Tel Aviv, Israel, SciSparc operates in the pharmaceuticals and biotech sectors, emphasizing cannabinoid technologies and related IP assets.
Profile Details
Type
Common Stock
Ceo
Mr. Oz Adler CPA
Address
Tower A
City
Tel Aviv-Yafo
Zip
6971916
Country
Israel
Phone
972 7 334 47180
